Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

Gencurix, a leading cancer molecular diagnostics company, has obtained approval from the Korean Ministry of Food and Drug Safety for its Droplex EGFR Mutation Test v2.